ArticleJFMS open reports
Mediastinal eosinophilic sclerosing fibroplasia associated with
Article in JFMS open reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Case summary: A 7-year-old female spayed domestic shorthair cat presented with respiratory distress. Initial diagnostics revealed a large cystic mass in the mediastinum and moderate hyperglobulinaemia. Additional abnormalities were ruled out through thoracic and abdominal CT. The mass was surgically removed, and antibiotic treatment was started based on cytological findings of intralesional bacteria. Histopathology and microbiology confirmed a severe inflammatory reaction pattern compatible with feline eosinophilic sclerosing fibroplasia (FESF) associated with Relevance and novel information: FESF, initially described as an inflammatory condition affecting the gastrointestinal tract, has also been anecdotally reported in other locations, including the retroperitoneum, retropharyngeal region and mediastinum. This report is the second to document a mediastinal presentation without concurrent abdominal involvement, and the first to achieve long-term remission without the use of immunosuppressants. It supports the hypothesis that FESF may represent a characteristic pattern of inflammation secondary to a range of triggers rather than a distinct disease process, indicating that treatment should probably target the specific underlying cause.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.